title: Vancomycin-induced red man syndrome in pediatric oncology: still an issue?
abstract: Red man syndrome is a rare but possibly serious adverse reaction during treatment with intravenous vancomycin. It is extremely important that pediatricians, especially in oncology, recognize this reaction and treat it appropriately. Following two case-reports from a pediatric oncology setting, a series of practical recommendations to prevent or handle red man syndrome are described.
authors.affiliation: Pharmacy, Ghent University Hospital, Ghent, Belgium. tiene.bauters@uzgent.be
authors.forename: Tiene
authors.initials: T
authors.lastname: Bauters
authors.forename: Barbara
authors.initials: B
authors.lastname: Claus
authors.forename: Petra
authors.initials: P
authors.lastname: Schelstraete
authors.forename: Hugo
authors.initials: H
authors.lastname: Robays
authors.forename: Yves
authors.initials: Y
authors.lastname: Benoit
authors.forename: Catharina
authors.initials: C
authors.lastname: Dhooge
mesh_terms: D000293:Adolescent; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000009:adverse effects*; D002675:Child, Preschool; D003875:Drug Eruptions / Q000175:diagnosis / Q000209:etiology*; D004890:Erythema / Q000139:chemically induced* / Q000175:diagnosis; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D011537:Pruritus / Q000139:chemically induced / Q000175:diagnosis; D013577:Syndrome; D014640:Vancomycin / Q000008:administration & dosage / Q000009:adverse effects*
chemical_list: D000900:Anti-Bacterial Agents; D014640:Vancomycin